Fundz

Fuse Biotherapeutics, Inc. reported raising $2.62 Million in an initial SEC Form D filing, from an offering of $7.07 Million

PRIVATEJul 09, 2021$2.6M of $7.1M raised

Amount Raised

$2.62 Million

$2.62 Million sold, per SEC Form D (first sale Jul 9, 2021)

Round Type

Seed

Los AngelesHealthcare

Quick answer

Fuse Biotherapeutics, Inc. raised $2.62 Million in a Seed round, dated July 9, 2021. Fuse Biotherapeutics, Inc. is based in Los Angeles, California, United States.

How much did Fuse Biotherapeutics, Inc. raise?
Fuse Biotherapeutics, Inc. raised $2.62 Million in a Seed round on July 9, 2021.
What does Fuse Biotherapeutics, Inc. do?
Fuse Biotherapeutics, Inc. is a biotechnology company that is dedicated to developing transformative immune modulating therapeutics for patients with cancer.
Where is Fuse Biotherapeutics, Inc. based and how big is it?
Fuse Biotherapeutics, Inc. is based in Los Angeles, California, United States.

Source: Fundz verified event record.

Who else raised in Healthcare around the same time

Companies in the same sectors as Fuse Biotherapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • Covera Health raised $25M (Series C) on August 23, 2021.
  • Tend Health raised $1.3M (Seed) on August 23, 2021.
  • Kiora Pharmaceuticals raised $11M on August 23, 2021.
  • Obstetrx, Inc. raised $1.1M (Seed) on August 20, 2021.
  • Rosy Wellness, Inc. raised $3.2M (Seed) on August 20, 2021.
  • Covera Health raised $22M on August 19, 2021.

Who to call at Fuse Biotherapeutics, Inc., and when

A new round usually means Fuse Biotherapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Fuse Biotherapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Fuse Biotherapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Fuse Biotherapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Fuse Biotherapeutics, Inc.

Location

6080 CENTER DRIVE

Los Angeles, California, United States

About

Fuse Biotherapeutics, Inc. is a biotechnology company that is dedicated to developing transformative immune modulating therapeutics for patients with cancer.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Fuse Biotherapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Fuse Biotherapeutics, Inc.'s next move

See what Strategic adds

Fuse Biotherapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.